ArticleCEN case reports2026

Regression of uremic tumoral calcinosis following the switch from cinacalcet to etelcalcetide in a hemodialysis patient without severe hyperphosphatemia.

Takuya Hase et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.